Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.1M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$34.8M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$33.2M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$30.7M |
| 5 |
DaVita
DVA
|
+$30.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$170M |
| 2 |
STJ
St Jude Medical
STJ
|
+$40.7M |
| 3 |
Danaher
DHR
|
+$37.7M |
| 4 |
Mettler-Toledo International
MTD
|
+$34M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$32.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.81% |
| 2 | Consumer Discretionary | 10.65% |
| 3 | Industrials | 10.41% |
| 4 | Healthcare | 10.37% |
| 5 | Technology | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Old Republic International
ORI
$10.1B
| $365K | 0.01% |
17,800
-3,500
| -16% | -$70.7K |
|
877
CACI
CACI
$14B
| $364K | 0.01% |
3,100
-806
| -21% | -$100K |
|
878
LivaNova
LIVN
$4.32B
| $364K | 0.01% |
7,428
-9,459
| -56% | -$460K |
|
879
Columbia Banking Systems
COLB
$8.71B
| $363K | 0.01% |
9,313
+3,849
| +70% | +$155K |
|
|
SUP
880
DELISTED
Superior Industries International
SUP
| $363K | 0.01% |
+14,300
| New | +$351K |
|
|
TLRD
881
DELISTED
Tailored Brands, Inc.
TLRD
| $363K | 0.01% |
24,300
-21,430
| -47% | -$431K |
|
|
IMPV
882
DELISTED
Imperva, Inc.
IMPV
| $363K | 0.01% |
+8,840
| New | +$369K |
|
|
MANT
883
DELISTED
Mantech International Corp
MANT
| $362K | 0.01% |
10,466
+4,429
| +73% | +$169K |
|
884
Verisk Analytics
VRSK
$24.7B
| $361K | 0.01% |
+4,446
| New | +$365K |
|
885
NeoGenomics
NEO
$2.1B
| $360K | 0.01% |
45,632
+18,762
| +70% | +$153K |
|
886
Microchip Technology
MCHP
$40.2B
| $359K | 0.01% |
+9,736
| New | +$343K |
|
887
Materion
MTRN
$4.81B
| $359K | 0.01% |
+10,700
| New | +$393K |
|
888
Northwest Bancshares
NWBI
$2.26B
| $359K | 0.01% |
21,300
-25,760
| -55% | -$452K |
|
|
SBNY
889
DELISTED
Signature Bank
SBNY
| $359K | 0.01% |
2,418
+14
| +0.6% | +$2.17K |
|
|
SVC
890
Service Properties Trust
SVC
$1.04B
| $358K | 0.01% |
2,270
-1,229
| -35% | -$192K |
|
|
NATI
891
DELISTED
National Instruments Corp
NATI
| $358K | 0.01% |
+10,987
| New | +$350K |
|
892
Kimberly-Clark
KMB
$37B
| $356K | 0.01% |
+2,701
| New | +$341K |
|
893
Rollins
ROL
$17.9B
| $356K | 0.01% |
+21,546
| New | +$341K |
|
|
OSG
894
Octave Specialty Group
OSG
$205M
| $355K | 0.01% |
18,800
+8,300
| +79% | +$175K |
|
895
Cheesecake Factory
CAKE
$5.7B
| $355K | 0.01% |
5,600
-16,078
| -74% | -$979K |
|
896
Cogent Communications
CCOI
$490M
| $355K | 0.01% |
+8,252
| New | +$344K |
|
897
United Fire Group
UFCS
$1.39B
| $355K | 0.01% |
+8,300
| New | +$373K |
|
|
DPLO
898
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $355K | 0.01% |
22,261
-12,639
| -36% | -$182K |
|
|
GCI
899
DELISTED
Gannett Co., Inc
GCI
| $355K | 0.01% |
42,374
-13,626
| -24% | -$122K |
|
900
Cabot Corp
CBT
$4.31B
| $354K | 0.01% |
5,913
-5,581
| -49% | -$317K |
|
Similar funds
Paul Tudor Jones's Q1 2017 Portfolio in Review
As of Q1 2017, Paul Tudor Jones held 1,687 positions worth $3.25B, down 16% from $3.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Paul Tudor Jones withdrew a net $793M in Q1 2017, closing 340 positions and reducing 514 holdings. Its most notable exit was St Jude Medical, an estimated $40.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Paul Tudor Jones opened a new position in iShares MSCI Emerging Markets ETF worth $72.8M.
- Paul Tudor Jones's largest Q1 2017 buy was iShares MSCI Emerging Markets ETF: 1,847,000 shares worth $72.8M.
- Paul Tudor Jones added most to Mead Johnson Nutrition Company in Q1 2017, an estimated $30.7M increase.
- Paul Tudor Jones's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $170M.
- Paul Tudor Jones fully exited St Jude Medical in Q1 2017, selling an estimated $40.7M.
- Paul Tudor Jones's ten largest holdings make up 31% of its $3.25B portfolio in Q1 2017.
- Paul Tudor Jones opened 332 new positions and closed 340 in Q1 2017.
- Paul Tudor Jones's portfolio value fell 16% quarter-over-quarter to $3.25B.
Based on Tudor Investment Corp's 13F filing for Q1 2017, filed 15 May 2017.